Descending modulation of neuropathic hypersensitivity by dopamine D2 receptors in or adjacent to the hypothalamic A11 cell group

Pharmacological Research

Volumn 59, Issue 5, 2009, Pages 355-363

  Wei, Hong ^a   Viisanen, Hanna ^a   Pertovaara, Antti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

A11; Descending pathways; Dopamine D2 receptor; Dopaminergic pain control; GABAA receptor; Neuropathic pain

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ATIPAMEZOLE; BICUCULLINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; L 741626; MUSCIMOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROTRANSMITTER RECEPTOR; QUINPIROLE; RACLOPRIDE; SEROTONIN 1A RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CANNULA; CATHETER; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTROSTIMULATION; HYPOTHALAMUS; LOCUS CERULEUS; MALE; NERVE LIGATION; NEUROPATHY; NOCICEPTION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SPINAL NERVE; WITHDRAWAL REFLEX;

ANIMALS; EFFERENT PATHWAYS; HYPOTHALAMUS; MALE; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSICAL STIMULATION; RATS; RATS, INBRED STRAINS; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-A; SPINAL CORD;

EID: 63349093316     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.01.001     Document Type: Article

References (49)

1. Hökfelt T., Phillipson O., and Goldstein M. Evidence for a dopaminergic pathway in the rat descending from the A11 cell group to the spinal cord. Acta Physiol Scand 107 (1979) 393-395
2. Skagerberg G., and Lindvall O. Organization of diencephalic dopamine neurons projecting to the spinal cord in the rat. Brain Res 342 (1985) 340-351
3. Qu S., Ondo W.G., Zhang X., Xie W.J., Pan T.H., and Le W.D. Projections of diencephalic dopamine neurons into the spinal cord in mice. Exp Brain Res 168 (2006) 152-156
4. Jensen T.S., and Yaksh T.L. Effects of intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious responses in rats. Brain Res 296 (1984) 285-293
5. Barasi S., and Duggal K.N. The effect of local and systemic application of dopaminergic agents on tail flick latency in the rat. Eur J Pharmacol 117 (1985) 287-294
6. Liu Q.S., Qiao J.T., and Dafny N. D2 dopamine receptor involvement in spinal dopamine-produced antinociception. Life Sci 51 (1992) 1485-1492
7. Gao X., Zhang Y., and Wu G. Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats. Eur J Pharmacol 418 (2001) 73-77
8. Fleetwood-Walker S.M., Hope P.J., and Mitchell R. Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. J Physiol (Lond) 399 (1988) 335-348
9. Gao X., Zhang Y.O., Zhang L.M., and Wu G.C. Effects of intraplantar injection of carrageenan on central dopamine release. Brain Res Bull 54 (2001) 391-394
10. Paulus W., Dowling P., Rijsman R., Stiasny-Kolster K., Trenkwalder C., and de Weerd A. Pathophysiological concepts of restless legs syndrome. Mov Disord 22 (2007) 1451-1456
11. 125I]iodosulpride. Neuroscience 20 (1987) 117-155
12. Reisine T.D., Nagy J.I., Beaumont K., Fibiger H.C., and Yamamura H.I. The localization of receptor binding sites in the substantia nigra and striatum of the rat. Brain Res 177 (1979) 241-252
13. White F.J., and Wang R.J. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221 (1983) 1054-1057
14. 2 dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine, but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin. Eur J Pharmacol 84 (1982) 211-214
15. Brown F., Campbell W., Mitchell P.J., and Randall K. Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis. Br J Pharmacol 84 (1985) 853-860
16. van den Pol A.N. Tyrosine hydroxylase immunoreactive neurons throughout the hypothalamus receive glutamate decarboxylase immunoreactive synapses: a double pre-embedding immunocytochemical study with particulate silver and HRP. J Neurosci 6 (1986) 877-891
17. Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol 80 (2006) 53-83
18. McRae-Degueurce A., and Milon H. Serotonin and dopamine afferents to the rat locus coeruleus: a biochemical study after lesioning of the ventral mesencephalic tegmental-A10 region and the raphé dorsalis. Brain Res 263 (1983) 344-347
19. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
20. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press, Sydney
21. Ondo W.G., He Y., Rajasekaran S., and Le W.D. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome?. Mov Disord 15 (2000) 154-158
22. Størkson R.V., Kjørsvik A., Tjølsen A., and Hole K. Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Methods 65 (1996) 167-172
23. 2-adrenoceptors have opposite effects on pain-related behavior in the neuropathic rat. Eur J Pharmacol 551 (2006) 41-49
24. 1A receptors in endogenous regulation of neuropathic hypersensitivity in the rat. Eur J Pharmacol 535 (2006) 157-165
25. Pertovaara A., and Wei H. Dual influence of the striatum on neuropathic hypersensitivity. Pain 137 (2008) 50-59
26. 2-adrenoceptor antagonist. CNS Drug Rev 11 (2005) 273-288
27. Martelle J.L., and Nader M.A. A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride. CNS Neurosci Ther 14 (2008) 248-262
28. Millan M.J. Descending control of pain. Prog Neurobiol 66 (2002) 355-474
29. Pertovaara A., and Almeida A. Descending inhibitory systems. In: Cervero F., and Jensen T.S. (Eds). Handbook of clinical neurology vol. 81 (2006), Elsevier, Amsterdam 179-192
30. Levant B., and McCarson K.E. D3 dopamine receptors in rat spinal cord: Implications for sensory and motor function. Neurosci Lett 303 (2001) 9-12
31. Scadding J.W., and Koltzenburg M. Painful peripheral neuropathies. In: McMahon S.B., and Koltzenburg M. (Eds). Wall and Melzack's textbook of pain. 5th ed. (2006), Elsevier, China 973-999
32. Luukko M., Konttinen Y., Kemppinen P., and Pertovaara A. Influence of various experimental parameters on the incidence of thermal and mechanical hyperalgesia induced by a constriction mononeuropathy of the sciatic nerve in lightly anesthetized rats. Exp Neurol 28 (1994) 143-154
33. Kauppila T., Kontinen V.K., and Pertovaara A. Weight bearing of the limb as a confounding factor in assessment of mechanical allodynia in the rat. Pain 74 (1998) 55-59
34. Hagelberg N., Jääskeläinen S.K., Martikainen I.K., Mansikka H., Forssell H., Scheinin H., et al. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol 500 (2004) 187-192
35. Wood P.B. Role of central dopamine in pain and analgesia. Expert Rev Neurother 8 (2008) 781-797
36. Paalzow G.H., and Paalzow L.K. Opposing effects of apomorphine on pain in rats. Evaluation of the dose-response curve. Eur J Pharmacol 88 (1983) 27-35
37. Zarrindast M.R., Nassiri-Rad S., and Pazouki M. Effects of dopaminergic agents on antinociception in formalin test. Gen Pharmacol 32 (1999) 517-522
38. Pelissier T., Laurido C., Hernandez A., Constandil L., and Eschalier A. Biphasic effect of apomorphine on rat nociception and effect of dopamine D2 receptor antagonists. Eur J Pharmacol 546 (2006) 40-47
39. Munro G. Dopamine D1 and D2 receptor agonism enhances antinociception mediated by the serotonin and noradrenaline reuptake inhibitor duloxetine in the rat formalin test. Eur J Pharmacol 575 (2007) 66-74
40. Gao X., Zhang Y., and Wu G. Effects of dopaminergic agents on carrageenan hyperalgesia in rats. Eur J Pharmacol 406 (2000) 53-58
41. Tamae A., Nakatsuka T., Koga K., Kato G., Furue H., Katafuchi T., et al. Direct inhibition of substantia gelatinosa neurones in the rat spinal cord by activation of dopamine D2-like receptors. J Physiol (Lond) 568 (2005) 243-253
42. 2 receptors in the dorsolateral striatum. Brain Res 855 (2000) 260-266
43. Ansah O.B., Leite-Almeida H., Wei H., and Pertovaara A. Striatal dopamine D2 receptors attenuate neuropathic hypersensitivity in the rat. Exp Neurol 205 (2007) 536-546
44. Taylor B.K., Joshi C., and Uppal H. Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res 987 (2003) 135-143
45. Coffeen U., López-Avila A., Ortega-Legaspi J.M., Del Ángel R., López-Muñoz F.J., and Pellicer F. Dopamine receptors in the anterior insular cortex modulate long-term nociception in the rat. Eur J Pain 12 (2008) 535-543
46. López-Avila A., Coffeen U., Ortega-Legaspi J.M., del Ángel R., and Pellicer F. Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex. Pain 111 (2004) 136-143
47. Tanabe M., Takasu K., Takeuchi Y., and Ono H. Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury. J Neurosci Res 86 (2008) 3258-3264
48. Aston-Jones G., Shipley M.T., Chouvet G., Ennis M., van Bockstaele E., Pieribone V., et al. Afferent regulation of locus coeruleus neurons: anatomy, physiology, and pharmacology. Prog Brain Res 88 (1991) 47-75
49. Iwasaki H., Kani K., and Maeda T. Neural connections of the pontine reticular formation, which connects reciprocally with the nucleus prepositus hypoglossi in the rat. Neuroscience 93 (1999) 195-208